People: Advaxis Inc (ADXS.OQ)
18 Sep 2019
Mr. Kenneth A. Berlin is President, Chief Executive Officer, Director of the company. He joins Advaxis from Rosetta Genomics, where since 2009 he was President and Chief Executive Officer. Prior to Rosetta Genomics, Mr. Berlin was Worldwide General Manager at cellular and molecular cancer diagnostics developer Veridex, LLC, a Johnson & Johnson company. Mr. Berlin joined Johnson & Johnson in 1994, and served as corporate counsel for six years. He led and participated on the legal team that oversaw several mergers, acquisitions, divestitures and commercial transactions. He then held positions of increasing responsibility within Johnson & Johnson and a number of its subsidiary companies. From 2001 until 2004 he served as Vice President, Licensing and New Business Development in the pharmaceuticals group, and from 2004 until 2007 served as Worldwide Vice President, Franchise Development, Ortho-Clinical Diagnostics.
|Total Annual Compensation, USD||427,353|
|Restricted Stock Award, USD||405,000|
|Long-Term Incentive Plans, USD||--|
|All Other, USD||965,103|
|Fiscal Year Total, USD||1,797,460|